I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 7 studies | 29% ± 11% | |
| GABAergic neuron | 3 studies | 25% ± 6% | |
| glutamatergic neuron | 3 studies | 34% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 7 studies | 29% ± 11% | |
| GABAergic neuron | 3 studies | 25% ± 6% | |
| glutamatergic neuron | 3 studies | 34% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 4079.58 | 2639 / 2642 | 100% | 82.48 | 703 / 705 |
| ovary | 76% | 400.37 | 137 / 180 | 47% | 1.59 | 200 / 430 |
| eye | 0% | 0 | 0 / 0 | 99% | 25.45 | 79 / 80 |
| thymus | 43% | 233.59 | 283 / 653 | 48% | 1.76 | 289 / 605 |
| skin | 14% | 77.79 | 256 / 1809 | 72% | 9.28 | 342 / 472 |
| muscle | 78% | 2664.59 | 624 / 803 | 0% | 0 | 0 / 0 |
| prostate | 20% | 107.34 | 49 / 245 | 55% | 2.00 | 277 / 502 |
| esophagus | 34% | 202.32 | 492 / 1445 | 28% | 0.82 | 51 / 183 |
| blood vessel | 58% | 353.28 | 778 / 1335 | 0% | 0 | 0 / 0 |
| breast | 33% | 215.17 | 152 / 459 | 24% | 0.74 | 269 / 1118 |
| stomach | 14% | 67.88 | 49 / 359 | 40% | 1.57 | 115 / 286 |
| bladder | 19% | 109.48 | 4 / 21 | 34% | 1.26 | 169 / 504 |
| uterus | 24% | 150.39 | 41 / 170 | 26% | 1.73 | 121 / 459 |
| intestine | 12% | 61.15 | 112 / 966 | 38% | 1.47 | 199 / 527 |
| pancreas | 0% | 0 | 0 / 328 | 48% | 1.81 | 85 / 178 |
| adipose | 42% | 269.63 | 509 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 4.55 | 3 / 258 | 34% | 1.43 | 78 / 230 |
| lung | 10% | 41.52 | 55 / 578 | 19% | 0.64 | 224 / 1155 |
| heart | 25% | 166.29 | 217 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 20% | 1.62 | 80 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.07 | 13 / 901 |
| peripheral blood | 0% | 1.51 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_1903707 | Biological process | negative regulation of hemopoiesis |
| GO_0006954 | Biological process | inflammatory response |
| GO_0032755 | Biological process | positive regulation of interleukin-6 production |
| GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
| GO_0032757 | Biological process | positive regulation of interleukin-8 production |
| GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
| GO_0005615 | Cellular component | extracellular space |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0005125 | Molecular function | cytokine activity |
| GO_0048018 | Molecular function | receptor ligand activity |
| Gene name | IL17D |
| Protein name | Interleukin-17D (IL-17D) (Interleukin-27) (IL-27) Interleukin 17D |
| Synonyms | UNQ3096/PRO21175 |
| Description | FUNCTION: Induces expression of IL6, CXCL8/IL8, and CSF2/GM-CSF from endothelial cells. . |
| Accessions | A0A087WWZ4 A0A087WW17 ENST00000498088.1 ENST00000304920.3 ENST00000468605.1 ENST00000682841.1 Q8TAD2 |
